FDA approves generic pediatric antibiotic

Article

The Food and Drug Administration gave the okay to Ranbaxy Laboratories for its pediatric formulation of the generic antibiotic cefuroxime axetil.

The Food and Drug Administration gave the okay to Ranbaxy Laboratories for its pediatric formulation of the generic antibiotic cefuroxime axetil.

The drug, which is also sold as GlaxoSmithKline's Ceftin, is indicated for treatment of mild to moderate pharyngitis/tonsillitis, acute bacterial otitis media, and impetigo in patients 3 months to 12 years old. Two dose sizes have been approved, 125 mg/5 ml and 250 mg/5 ml.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
John Browning, MD, provides practical skincare reminders ahead of summer season
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Related Content
Early antibiotic exposure disrupts infant immune memory, study shows | Image Credit: © Anatta_Tan - stock.adobe.com.

Early antibiotic exposure disrupts infant immune memory, study shows

Morgan Ebert, Managing Editor
July 15th 2025
Article

Early antibiotic exposure disrupts infant immune development by altering gut microbiota, highlighting inosine's potential as a therapeutic target for immune restoration.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
Jeanne Marconi, MD

Understanding neurodiversity: What every parent and pediatrician should know when it comes to your child’s brain development

Jeanne Marconi, MD
July 14th 2025
Article

Parents and pediatricians navigate the complexities of neurodiversity, emphasizing the need for open communication and better resources for child development.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
FDA approves gardenia blue as natural color additive for food use | Image credit: Contemporary Pediatrics

FDA approves gardenia blue as natural color additive for food use

Morgan Ebert, Managing Editor
July 14th 2025
Article

The FDA approves gardenia (genipin) blue as a natural food color, enhancing options for manufacturers and supporting the shift away from synthetic dyes.

Neonatal deaths in the US decline overall, but malnutrition-related mortality rises | Image Credit: © Sergey Novikov - stock.adobe.com.

Neonatal deaths in the US decline overall, but malnutrition-related mortality rises

Morgan Ebert, Managing Editor
July 11th 2025
Article

A study reveals declining US neonatal mortality overall, yet highlights rising deaths from fetal malnutrition, emphasizing ongoing disparities in neonatal health outcomes.

© 2025 MJH Life Sciences

All rights reserved.